TAIWAN · TWSE / TPEx
OBIGEN PHARMA
鼎晉生技 · 7876 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$69.401 month +38.2% · 1 year —
Directors and supervisors hold58,001,50054.1% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold53,001,50049.4% of shares issued
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 台灣浩鼎生技股份有限公司 | Chairman · Director · Major shareholder (10%+) | 53,001,500 | 53,001,500 | 49.41% | — | — |
| 蔣永芳 | Chairman (corporate representative) | — | 0 | — | — | — |
| 馬海怡 | Director (corporate representative) | — | 32,000 | 0.03% | — | — |
| 潤泰興股份有限公司 | Director | 5,000,000 | 5,000,000 | 4.66% | — | — |
| 尹崇堯 | Director (corporate representative) | — | 0 | — | — | — |
| 周珮芬 | Director · President | — | 0 | — | — | — |
| 張振武 | Independent director | — | 0 | — | — | — |
| 陳松柏 | Independent director | — | 0 | — | — | — |
| 劉永富 | Independent director | — | 0 | — | — | — |
| 沈冠成 | Manager | — | 182,500 | 0.17% | — | — |
| 何俊德 | Manager | — | 5,000 | 0.00% | — | — |
| 王永凱 | Manager | — | 239,000 | 0.22% | — | — |
| 曹子文 | Assistant vice president | — | 270,000 | 0.25% | — | — |
| 江美姈 | Assistant vice president | — | 15,000 | 0.01% | — | — |
| 蔡承儒 | Deputy manager | — | 15,000 | 0.01% | — | — |
| 吳昌民 | Chief financial officer · Chief accountant | — | 0 | — | — | — |